By Health In Five Writer
Voxtur Bio has launched an advanced point of care rapid Neutralising antibody test kit VoxPress COVID-19 for detecting neutralising antibodies.
Neutralising antibody tests monitor or detect prior COVID-19 infection, confirm if someone has produced an immune response following infection and monitor antibody vaccine response.
According to the company statement, “It comes with rapid turnaround time (15 minutes), high specificity (94 per cent) and sensitivity (100 per cent) and long shelf life of 24 months. It has advantages over the other methods in many ways such as no specific laboratory requirements, no need for specific training of the analyst along with field applicability, easy scalability and mass screening possibility. It will prove useful for the authorities in the government to take decisions on either maintaining or relaxing the COVID restrictions. By facilitating pre-screening of patients prior to vaccination, it can also support immunisation usage and deployment.”
The neutralising antibody rapid test gives information on the presence or absence of a neutralising antibody. VoxPress COVID-19 neutralising antibody is a lateral flow test that detects IgG antibodies to spike protein of the SARS-CoV-2 virus, from a small finger prick of blood in only 15 minutes.
Dr Veeraal Gandhi, Managing Director and Chairman, Voxtur Bio said, “VoxPress COVID-19 will help in COVID-19 investigations of sero-prevalence, assessing herd immunity, the long existence of protective immunity, and the efficacy of different vaccine candidates as well as tracking chain of infection. The kit will facilitate qualitative detection of neutralising antibody in Serum, Plasma or Whole blood specimens of previously infected or COVID-19 vaccinated individuals. Largescale antibody testing would help to identify immune individuals, allowing them to carry on with their day-to-day lives. Having said that, critical for contagion, negative antibody testing would identify those that are not immune, thus alerting those individuals to be more cautious. VoxPress COVID-19 will enable employers’ to offer a safe and convenient return to the work. As neutralising antibody tests are critical for adopting precautionary measures against COVID – 19 variants and ensuring effective roll-out of Covid 19 precaution booster dose, we have built with the dedicated manufacturing capacity to meet the demand.”